Projects per year
Personal profile
Keywords
- Interstitial lung disease
Projects 2017 2022
- 7 Active
A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis (ATLAS Study)
Glaspole, I. & Symons, K. M.
7/06/19 → 1/06/22
Project: Research
A Phase 3, randomized, double-blind, parallel-group, placebo controlled multicenter study to evaluate the efficacy and safety of two doses of GLPG1690 in addition to local standard of care for minimum 52 weeks in subjects with idiopathic pulmonary fibrosis.
Glaspole, I. & Symons, K. M.
7/06/19 → 1/12/22
Project: Research
Clinical and biological approaches to improving diagnostic confidence of Chronic Hypersensitivity Pneumonitis.
Glaspole, I. & Barnes, H.
4/03/19 → 3/03/22
Project: Research
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients with Idiopathic Pulmonary Fibrosis.
Glaspole, I. & Symons, K. M.
13/09/18 → 31/07/22
Project: Research
Circulatory biomarkers for Idiopathic Pulmonary Fibrosis: improving patient outcomes
Moodley, Y. P., Corte, T. J., Knight, D., Reynolds, P., Walters, E. H., Glaspole, I., Baltic, S., Sohal, S. & Grainge, C.
National Health & Medical Research Council (NHMRC)
1/01/18 → 31/12/20
Project: Research
Research Output 1997 2019
Comprehensive pulmonary rehabilitation for interstitial lung disease: A consensus approach to identify core education topics
Holland, A. E., Watson, A. & Glaspole, I., Jun 2019, In : Patient Education and Counseling. 102, 6, p. 1125-1130 6 p.Research output: Contribution to journal › Article › Research › peer-review
Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis
Nathan, S. D., Costabel, U., Glaspole, I., Glassberg, M. K., Lancaster, L. H., Lederer, D. J., Pereira, C. A., Trzaskoma, B., Morgenthien, E. A., Limb, S. L. & Wells, A. U., Apr 2019, In : Chest. 155, 4, p. 712-719 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing
Burgess, A., Goon, K., Brannan, J. D., Attia, J., Palazzi, K., Oldmeadow, C., Corte, T. J., Glaspole, I., Goh, N., Keir, G., Allan, H., Chapman, S., Cooper, W., Ellis, S., Hopkins, P., Moodley, Y., Reynolds, P., Zappala, C., Macansh, S. & Grainge, C., 1 Jan 2019, (Accepted/In press) In : Respirology. 8 p.Research output: Contribution to journal › Article › Research › peer-review
Exertional Desaturation and Prescription of Ambulatory Oxygen Therapy in Interstitial Lung Disease
Khor, Y. H., Goh, N. S., Glaspole, I., Holland, A. E. & McDonald, C. F., 1 Mar 2019, In : Respiratory care. 64, 3, p. 299-306 8 p.Research output: Contribution to journal › Article › Research › peer-review
Gastroesophageal reflux and antacid therapy in IPF: Analysis from the Australia IPF Registry
Jo, H. E., Corte, T. J., Glaspole, I., Grainge, C., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Chapman, S., Walters, E. H., Zappala, C., Allan, H., Keir, G. J., Cooper, W. A., Mahar, A. M., Ellis, S., MacAnsh, S. & Goh, N. S., 3 May 2019, In : BMC Pulmonary Medicine. 19, 1, 7 p., 84.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File